Apramycin

Structural formula
General
Non-proprietary name	Apramycin
other names	4- O - ((8 R ) -2-Amino-8- O - (4-amino-4-deoxy-α- D -glucopyranosyl) -2,3,7-trideoxy-7- (methylamino) - D - glycero-α- D -allo-octodialdo-1,5: 8,4-dipyranos-1-yl) -deoxy- D -streptamine; (2 R , 3 R , 4 R , 5 S , 6 R ) -5-amino-2 - [((1 R , 2 R , 3 R , 4 R , 6 R , 8 R ) -8-amino-9 - [(1R, 2S, 3R, 4R, 6R) -4,6-diamino-2,3-dihydroxy-cyclohexyl] oxy-2-hydroxy-3-methylamino-5,10-dioxabicyclo [4.4.0] dec- 4-yl) oxy] 6- (hydroxymethyl) oxane-3,4-diol;
Molecular formula	C 21 H 41 N 5 O 11
External identifiers / databases
EC number	253-460-1
ECHA InfoCard	100,048,582
PubChem	3081545
DrugBank	DB04626
Wikidata	Q418940
Drug information
ATC code	Q A07AA92
Drug class	Antibiotic , aminoglycosides
properties
Molar mass	539.58 g mol −1
safety instructions
	Please note the exemption from the labeling requirement for drugs, medical devices, cosmetics, food and animal feed
H and P phrases	H: 315-319-360
	P: 201-305 + 351 + 338-308 + 313
	As far as possible and customary, SI units are used. Unless otherwise noted, the data given apply to standard conditions .

Apramycin is an aminoglycoside antibiotic that is used exclusively in veterinary medicinal products . Apramycin is approved for pigs , rabbits , sheep , cattle and chickens in countries of the European Union . It must not be used in animals from which eggs or milk are obtained for human consumption.

Examples of application areas:

Trade names